Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1685 (LINC01685) is a human long intergenic non-coding RNA (lincRNA) belonging to the class of long non-coding RNAs, which are RNA transcripts longer than 200 nucleotides that do not encode proteins and are located between protein-coding genes[1][3][5]. LincRNAs are known for their diverse regulatory roles in gene expression, chromatin architecture, and RNA stabilization, often exhibiting tissue-specific expression patterns and regulatory mechanisms[3][5]. While many lincRNAs—including LINC01685—are increasingly annotated and studied, the specific biological functions and disease associations of LINC01685 remain largely uncharacterized at present[1]. There is no robust evidence designating LINC01685 as a validated therapeutic target or as a clinically actionable biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1685 (LINC01685).